These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33627152)

  • 1. Au-siRNA@ aptamer nanocages as a high-efficiency drug and gene delivery system for targeted lung cancer therapy.
    Yang Y; Han Y; Sun Q; Cheng J; Yue C; Liu Y; Song J; Jin W; Ding X; de la Fuente JM; Ni J; Wang X; Cui D
    J Nanobiotechnology; 2021 Feb; 19(1):54. PubMed ID: 33627152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of aptamer-siRNA chimera and glutamine modified carboxymethyl-β-cyclodextrin nanoparticles for the combination therapy against lung squamous cell carcinoma.
    Hao Y; Yang J; Liu D; Zhang H; Ou T; Xiao L; Chen W
    Biomed Pharmacother; 2024 May; 174():116506. PubMed ID: 38554525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-delivery of doxorubicin and aptamer against Forkhead box M1 using chitosan-gold nanoparticles coated with nucleolin aptamer for synergistic treatment of cancer cells.
    Khademi Z; Lavaee P; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    Carbohydr Polym; 2020 Nov; 248():116735. PubMed ID: 32919550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
    Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
    Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facile Construction of i-Motif DNA-Conjugated Gold Nanostars as Near-Infrared and pH Dual-Responsive Targeted Drug Delivery Systems for Combined Cancer Therapy.
    Miao D; Yu Y; Chen Y; Liu Y; Su G
    Mol Pharm; 2020 Apr; 17(4):1127-1138. PubMed ID: 32092274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamer-functionalized gold nanoparticles as photoresponsive nanoplatform for co-drug delivery.
    Shiao YS; Chiu HH; Wu PH; Huang YF
    ACS Appl Mater Interfaces; 2014 Dec; 6(24):21832-41. PubMed ID: 24949657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terminal Deoxynucleotidyl Transferase-Catalyzed Preparation of pH-Responsive DNA Nanocarriers for Tumor-Targeted Drug Delivery and Therapy.
    Sun GY; Du YC; Cui YX; Wang J; Li XY; Tang AN; Kong DM
    ACS Appl Mater Interfaces; 2019 Apr; 11(16):14684-14692. PubMed ID: 30942569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy.
    Xiao Y; Jaskula-Sztul R; Javadi A; Xu W; Eide J; Dammalapati A; Kunnimalaiyaan M; Chen H; Gong S
    Nanoscale; 2012 Nov; 4(22):7185-93. PubMed ID: 23070403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery.
    Nie L; Sun S; Sun M; Zhou Q; Zhang Z; Zheng L; Wang L
    J Vis Exp; 2020 Jun; (160):. PubMed ID: 32658190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamer-Functionalized and Backbone Redox-Responsive Hyperbranched Polymer for Targeted Drug Delivery in Cancer Therapy.
    Zhuang Y; Deng H; Su Y; He L; Wang R; Tong G; He D; Zhu X
    Biomacromolecules; 2016 Jun; 17(6):2050-62. PubMed ID: 27113017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
    Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-staggered delivery of erlotinib and doxorubicin by gold nanocages with two smart polymers for reprogrammable release and synergistic with photothermal therapy.
    Feng Y; Cheng Y; Chang Y; Jian H; Zheng R; Wu X; Xu K; Wang L; Ma X; Li X; Zhang H
    Biomaterials; 2019 Oct; 217():119327. PubMed ID: 31299626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient delivery of therapeutic siRNA into glioblastoma cells using multifunctional dendrimer-entrapped gold nanoparticles.
    Kong L; Wu Y; Alves CS; Shi X
    Nanomedicine (Lond); 2016 Dec; 11(23):3103-3115. PubMed ID: 27809656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
    Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
    Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A54 peptide-mediated functionalized gold nanocages for targeted delivery of DOX as a combinational photothermal-chemotherapy for liver cancer.
    Huang S; Li C; Wang W; Li H; Sun Z; Song C; Li B; Duan S; Hu Y
    Int J Nanomedicine; 2017; 12():5163-5176. PubMed ID: 28790823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
    Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K
    Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer.
    Zhuang J; Chen S; Hu Y; Yang F; Huo Q; Xie N
    Int J Nanomedicine; 2021; 16():1961-1976. PubMed ID: 33727809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of gold nanoprism-assisted human PD-L1 siRNA on both gene down-regulation and photothermal therapy on lung cancer.
    Liu B; Cao W; Qiao G; Yao S; Pan S; Wang L; Yue C; Ma L; Liu Y; Cui D
    Acta Biomater; 2019 Nov; 99():307-319. PubMed ID: 31513911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
    Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
    Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    El-Ghareb WI; Swidan MM; Ibrahim IT; Abd El-Bary A; Tadros MI; Sakr TM
    Int J Pharm; 2020 Aug; 586():119514. PubMed ID: 32565281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.